Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2005
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050245477 Immunomodulatory oligonucleotides
11/03/2005US20050245475 Functional and hyperfunctional siRNA directed against Bcl-2
11/03/2005US20050245466 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
11/03/2005US20050245458 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
11/03/2005US20050245453 Peptides derived from cadherin and methods of use thereof
11/03/2005US20050245444 Method of using recombinant human antithrombin for neurocognitive disorders
11/03/2005US20050245440 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
11/03/2005US20050244987 Detection device, detection apparatus, and detection kit employing the device and reagent
11/03/2005US20050244955 A micro-pallet includes a small flat surface designed for single adherent cells to plate, a cell plating region designed to protect the cells, and shaping designed to enable or improve flow-through operation
11/03/2005US20050244954 Binding acceleration techniques for the detection of analytes
11/03/2005US20050244943 Cell concentration and pathogen recovery
11/03/2005US20050244933 Using varying infrared wavelengths for cyclic heating during DNA amplification
11/03/2005US20050244932 Inverted orientation for a microplate
11/03/2005US20050244921 Fluorescent protein variants and methods for making same
11/03/2005US20050244918 Methods for detecting bacterial pathogens
11/03/2005US20050244917 Device and method for detecting antibiotic inactivating enzymes
11/03/2005US20050244916 Methods for predicting protein activity based on identification of multidimensional signatures
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244914 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
11/03/2005US20050244913 determining lipoprotein-associated phospholipase A2 (Lp-PLA2) enzyme activity and inhibition of activity; colorimetry
11/03/2005US20050244912 Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase
11/03/2005US20050244911 Methods and reagents for treating autoimmune disorders
11/03/2005US20050244910 Methods for determining glycemic responses of foods
11/03/2005US20050244908 Direct assay of cholesterol in skin samples removed by tape stripping
11/03/2005US20050244907 Methods, compositions, and kits for analysis of enzyme activity in cells
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244891 Ligand-containing micelles and uses thereof
11/03/2005US20050244887 Nucleic acid amplification reaction station for disposable test devices
11/03/2005US20050244886 DNA analyzing apparatus, DNA sensor, and analyzing method
11/03/2005US20050244885 Using solid support comprising immobilized nucleic acid and cyclic polymerase amplification to generate preferential nucleotide sequence products; peptide mimetics
11/03/2005US20050244883 Method and computer software product for genomic alignment and assessment of the transcriptome
11/03/2005US20050244882 Isolation of nucleic acids on surfaces
11/03/2005US20050244880 Cellular arrays and methods of detecting and using genetic disorder markers
11/03/2005US20050244879 Multiplex amplification of short tandem repeat loci
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244876 Human tumor necrosis factor receptors TR13 and TR14
11/03/2005US20050244875 Sequencing preferential nucleotide sequences; obtain nucleotide sequences, insert preferential heavy elements into compound, insert into microscope, monitor base preferential labels, determine nucleotide sequence
11/03/2005US20050244874 Measuring interleukin-17A (IL-17A), IL-17F, or both in a non-lesional psoriatic skin sample using real-time polymerase chain reaction; determining at least 5-fold higher gene expression of IL-17A, IL-17F, or both; administering a IL-23 antagonist antibody or binding fragment; diagnosis
11/03/2005US20050244873 Detecting method, detection device and detection kit
11/03/2005US20050244872 Breast cancer gene expression biomarkers
11/03/2005US20050244871 Polynucleotide probe having enhanced binding specificity, microarray having the probe immobilized thereon, and method of designing the probe
11/03/2005US20050244870 Nucleic acid sequencing using microsphere arrays
11/03/2005US20050244869 Modulation of transthyretin expression
11/03/2005US20050244868 Ten-M3 polypeptides and polynucleotides and their methods of use
11/03/2005US20050244867 Growth factor HTTER36
11/03/2005US20050244866 Methods for reducing the range in concentrations of analyte species in a sample
11/03/2005US20050244865 Molecular lithography with DNA nanostructures
11/03/2005US20050244864 High throughput screening of probes; measurement of levels of unbound free fatty acids; use in drug screening or to determine the individual's risk for disease such as stroke, cardiac disease and cancer
11/03/2005US20050244863 Molecular arrays and single molecule detection
11/03/2005US20050244862 Identification of ligands by selective amplification of cells transfected with receptors
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244858 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/03/2005US20050244857 Death domain containing receptor 4
11/03/2005US20050244856 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
11/03/2005US20050244854 Novel method for the identification of clones conferring a desired biological property from an expression library
11/03/2005US20050244853 Determining relative expression for probe groups in probe arrays
11/03/2005US20050244852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/03/2005US20050244851 Methods of analysis of alternative splicing in human
11/03/2005US20050244850 Assembly of arrays on chips segmented from wafers
11/03/2005US20050244848 Mass spectrometric analysis of biopolymers
11/03/2005US20050244847 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
11/03/2005US20050244845 90 human secreted proteins
11/03/2005US20050244843 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
11/03/2005US20050244842 Promoter sequences
11/03/2005US20050244841 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/03/2005US20050244840 Method of screening anti-mycobacterial molecules
11/03/2005US20050244839 Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
11/03/2005US20050244837 Method and device for sample preparation control
11/03/2005US20050244836 Methods and compositions to detect bacteria using multiplex PCR
11/03/2005US20050244835 Amplifying CDNA, hybridizing, adding blocking solution and avidin enzyme or streptavidin horseradish peroxidase; detecting luminescence or color change; fast detection in less than 5 hours
11/03/2005US20050244834 Single nucleotide polymorphisms in genes
11/03/2005US20050244833 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/03/2005US20050244831 Target dna
11/03/2005US20050244830 Quantitative multiplex amplification on a genomic scale, and applications for detecting genomic rearrangements
11/03/2005US20050244828 Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma
11/03/2005US20050244827 Method
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244825 Regulation of human bmp-2 inducible kinase
11/03/2005US20050244824 Method of assaying target nucleic acid and kit therefor
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244822 Method of monitoring gene expression
11/03/2005US20050244821 Method of identification and quantification of biological molecules and apparatus therefore
11/03/2005US20050244820 Detecting molecular binding by monitoring feedback controlled cantilever deflections
11/03/2005US20050244819 Assay system for screening protease inhibitors
11/03/2005US20050244818 Single cell analysis of HIV replication capacity and drug resistance
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244816 Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics
11/03/2005US20050244815 Compositions and methods for viral resistance genes
11/03/2005US20050244813 Detection of human papillomavirus e6 mrna
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244811 Matrix array nanobiosensor
11/03/2005US20050244810 Taste signaling in gastrointestinal cells
11/03/2005US20050244809 Array biosensor and method of using same for detecting the concentration of one or more analytes in one or more biological samples
11/03/2005US20050244808 Subjecting a zebrafish larva to laser irradiation or exposing a zebrafish to water containing sodium hydroxide; the fish are used for identifing anti-thrombotic agents and for identifying genes associated with all aspects of thrombus formation
11/03/2005US20050244806 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
11/03/2005US20050244448 Diagnosis and treatment of disorders of collagen and elastin metabolism
11/03/2005US20050244434 Tat-based tolerogen compositions and methods of making and using same
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus